# TCRx_T Cells for Advanced or Recurrent Gastric/Gastroesophageal Junction Cancer After Failure of First Chemotherapy

> **NCT05447234** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 50 (estimated)

## Conditions studied

- Gastric Cancer
- Gastroesophageal-junction Cancer

## Interventions

- **BIOLOGICAL:** Tcrx T cell

## Key facts

- **NCT ID:** NCT05447234
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-03-01
- **Primary completion:** 2026-03-01
- **Final completion:** 2028-03-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-02-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05447234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05447234, "TCRx_T Cells for Advanced or Recurrent Gastric/Gastroesophageal Junction Cancer After Failure of First Chemotherapy". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT05447234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*